Legal status · United States
Is Rilmenidine legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Rilmenidine is not an approved medicine in the United States; its classification is "Not approved in the United States". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Rilmenidine in the United States at a glance
| Classification | Not approved in the United States |
|---|---|
| Note | No FDA marketing authorisation. It is a licensed antihypertensive in France and several other European markets, which is why longevity buyers source it from abroad. |
| FDA approval status | Not approved in the United States. Rilmenidine is a Servier product licensed as an antihypertensive in France and several other European markets under the names Hyperium, Tenaxum, Albarel and Iterium. |
| Human studies cited | 1 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Rilmenidine profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Rilmenidine is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Rilmenidine is
A European blood pressure drug that extends lifespan in Caenorhabditis elegans through the nischarin receptor. In mammals the record is worse than neutral: it induced autophagy as designed in two mouse models of motor neuron disease and made both of them worse.
Rilmenidine is a centrally acting antihypertensive that works through the I1-imidazoline receptor. It entered geroscience sideways, through a screen for compounds whose gene expression signature resembles caloric restriction, and it came out near the top.
Mechanism: Agonist at the I1-imidazoline receptor, with weaker alpha-2 adrenoceptor activity than clonidine, which is why it lowers blood pressure with less sedation. The geroscience mechanism proposed is induction of mTOR-independent autophagy plus a transcriptional state resembling caloric restriction.
Regulatory history: Not approved in the United States. Rilmenidine is a Servier product licensed as an antihypertensive in France and several other European markets under the names Hyperium, Tenaxum, Albarel and Iterium.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Rilmenidine at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Rilmenidine in other countries
Frequently asked questions
Is Rilmenidine legal in the United States?
No. Rilmenidine is not an approved medicine in the United States; its classification is "Not approved in the United States". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: No FDA marketing authorisation. It is a licensed antihypertensive in France and several other European markets, which is why longevity buyers source it from abroad.
Can I buy Rilmenidine in the United States?
No approved product exists to buy. In the United States Rilmenidine is classified as "Not approved in the United States", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No FDA marketing authorisation. It is a licensed antihypertensive in France and several other European markets, which is why longevity buyers source it from abroad.
Is Rilmenidine FDA approved?
No. FDA status: Not approved in the United States. Rilmenidine is a Servier product licensed as an antihypertensive in France and several other European markets under the names Hyperium, Tenaxum, Albarel and Iterium.. Current US classification: "Not approved in the United States". On the evidence, 1 human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Rilmenidine live on its compound profile.
Rilmenidine profileThis page is general information about the regulatory status of Rilmenidine in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.